Press Releases Year All News | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | Nov 12, 2019 TCR² Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update Oct 09, 2019 TCR² Therapeutics Appoints Industry Veteran Angela Justice, Ph.D., as Chief People Officer Sep 27, 2019 TCR² Therapeutics to Present at the Cantor Global Healthcare Conference Aug 30, 2019 TCR² Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference Aug 08, 2019 TCR² Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update Aug 06, 2019 TCR² Therapeutics to Participate in Upcoming Conferences in August Aug 06, 2019 TCR² Therapeutics Deepens Manufacturing and Immuno-Oncology Expertise with Key Hires Jul 31, 2019 TCR² Therapeutics Announces Partnership with the National Cancer Institute for Phase 1/2 Trial of TC-210 Jun 28, 2019 TCR² Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes May 13, 2019 TCR² Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update Pagination Current page 1 Page 2 Next page next › Last page last »